DelveInsight’s “Preeclampsia Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Preeclampsia, historical and forecasted epidemiology as well as the Preeclampsia market trends in the United States, EU4 (Germany, Spain, Italy, and France), United Kingdom, and Japan.
Key Takeaways from the Preeclampsia Market Report
- In December 2025,DiaMedica Therapeutics announced significant progress in its DM199 program for treating preeclampsia. Following a successful pre-IND meeting, the FDA requested an additional non-clinical study, with results expected by Q2 2026. Simultaneously, an ongoing Phase 2 investigator-sponsored trial in South Africa has demonstrated promising early safety and efficacy. DM199, a recombinant human tissue kallikrein-1, aims to improve blood flow and reduce blood pressure without crossing the placental barrier. These developments bolster the potential of DM199 as a novel therapeutic for a condition where delivery remains the only current treatment.
- The increase in Preeclampsia Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
- As per DelveInsight analysis, the Preeclampsia Market is anticipated to witness growth at a CAGR of 3.30% during the forecast period (2025-2036).
- The leading Preeclampsia Companies such as Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG, Comanche Biopharma, and others.
- Promising Preeclampsia Pipeline Therapies such as CBP-4888, DM199, and others.
- The Preeclampsia Market Size is expected to grow from USD 87 Million in 2025 to USD 116 Million by 2036.
Stay ahead in the Preeclampsia Therapeutics Market with DelveInsight’s Strategic Report @ Preeclampsia Market Outlook
Preeclampsia Epidemiology Segmentation in the 7MM
The epidemiology section of Preeclampsia offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Preeclampsia Epidemiology Trends @ Preeclampsia Prevalence
Preeclampsia Drugs Market
The Preeclampsia Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Preeclampsia are likely to uncover new therapeutic targets and further expand treatment options for patients.
Preeclampsia Treatment Market Landscape
The Preeclampsia treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of novel investigational therapies including siRNA and molecular approaches that target underlying mechanisms of preeclampsia has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Preeclampsia treatment guidelines, visit @ Preeclampsia Treatment Market Landscape
Preeclampsia Market Outlook
The report’s outlook on the Preeclampsia market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Preeclampsia therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Preeclampsia drug and late-stage pipeline therapy.
Preeclampsia Drugs Uptake
The drug chapter of the Preeclampsia report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages and disadvantages of each drug, as well as the latest news and press releases related to Preeclampsia.
Major Preeclampsia Companies
Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG, Comanche Biopharma, and others.
Learn more about the therapies for Preeclampsia @ Drugs for Preeclampsia Treatment
Scope of the Preeclampsia Market Report
- Coverage – 7MM
- Study Period – 2022-2036
- Preeclampsia Companies – Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG, Comanche Biopharma, and others.
- Preeclampsia Pipeline Therapies – CBP-4888, DM199, and others.
- Preeclampsia Market Dynamics: Preeclampsia Market Drivers and Barriers
- Preeclampsia Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Preeclampsia Drugs in development @ Preeclampsia Clinical Trials Assessment
Table of Content
- Key Insights
- Report Introduction
- Preeclampsia Market Overview at a Glance
- Preeclampsia Methodology
- Executive Summary
- Disease Background and Overview
- Treatment and Management of Preeclampsia
- Preeclampsia Epidemiology and Patient Population
- Preeclampsia Patient Journey
- Preeclampsia: Seven Major Market Analysis
- KOL Views
- SWOT Analysis
- Preeclampsia Unmet Needs
- Market Access and Reimbursement
- Appendix
- DelveInsight Capabilities
- Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
